NASDAQ:CLGN - COLLPLANT HOLDI/S Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$5.40 +0.05 (+0.93 %)
(As of 11/15/2018 11:31 AM ET)
Previous Close$5.35
Today's Range$5.40 - $5.40
52-Week Range$4.70 - $9.00
Volume200 shs
Average Volume12,942 shs
Market Capitalization$18.66 million
P/E Ratio-2.39
Dividend YieldN/A
BetaN/A
CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen (rhCollagen) that is produced with its proprietary plant based genetic engineering technology. The company's products include Vergenix STR, a soft tissue repair matrix intended for treatment of tendinopathy; Vergenix FG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd. and is headquartered in Ness Ziona, Israel.

Receive CLGN News and Ratings via Email

Sign-up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CLGN
Previous Symbol
CUSIPN/A
Phone972-73-232-5600

Debt

Debt-to-Equity Ratio0.37
Current Ratio3.97
Quick Ratio3.37

Price-To-Earnings

Trailing P/E Ratio-2.39
Forward P/E Ratio-6.35
P/E GrowthN/A

Sales & Book Value

Annual Sales$480,000.00
Price / Sales38.48
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)($2.26)
Net Income$-6,020,000.00
Net Margins-552.97%
Return on Equity-80.17%
Return on Assets-41.81%

Miscellaneous

Employees29
Outstanding Shares3,420,000
Market Cap$18.66 million
OptionableNot Optionable

COLLPLANT HOLDI/S (NASDAQ:CLGN) Frequently Asked Questions

What is COLLPLANT HOLDI/S's stock symbol?

COLLPLANT HOLDI/S trades on the NASDAQ under the ticker symbol "CLGN."

How were COLLPLANT HOLDI/S's earnings last quarter?

COLLPLANT HOLDI/S (NASDAQ:CLGN) announced its quarterly earnings data on Friday, September, 21st. The company reported ($0.27) earnings per share (EPS) for the quarter. The company earned $0.17 million during the quarter. COLLPLANT HOLDI/S had a negative return on equity of 80.17% and a negative net margin of 552.97%. View COLLPLANT HOLDI/S's Earnings History.

When is COLLPLANT HOLDI/S's next earnings date?

COLLPLANT HOLDI/S is scheduled to release their next quarterly earnings announcement on Monday, February 11th 2019. View Earnings Estimates for COLLPLANT HOLDI/S.

Has COLLPLANT HOLDI/S been receiving favorable news coverage?

Press coverage about CLGN stock has trended somewhat positive this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. COLLPLANT HOLDI/S earned a news impact score of 1.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 9.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near future.

Who are some of COLLPLANT HOLDI/S's key competitors?

Who are COLLPLANT HOLDI/S's key executives?

COLLPLANT HOLDI/S's management team includes the folowing people:
  • Mr. Yehiel Tal, Chief Exec. Officer (Age 66)
  • Prof. Oded Shoseyov, Founder and Chief Scientist Officer (Age 62)
  • Mr. Eran Rotem, Deputy CEO & CFO (Age 50)
  • Dr. Philippe David Bensimon, VP of Regulation Affairs and Quality Assurance (Age 53)
  • Dr. Nadav Orr, VP of R&D (Age 61)

When did COLLPLANT HOLDI/S IPO?

(CLGN) raised $22 million in an initial public offering on Friday, December 9th 2016. The company issued 3,500,000 shares at $6.23 per share. Ladenburg Thalmann acted as the underwriter for the IPO and Roth Capital Partners was co-manager.

How do I buy shares of COLLPLANT HOLDI/S?

Shares of CLGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is COLLPLANT HOLDI/S's stock price today?

One share of CLGN stock can currently be purchased for approximately $5.50.

How big of a company is COLLPLANT HOLDI/S?

COLLPLANT HOLDI/S has a market capitalization of $18.66 million and generates $480,000.00 in revenue each year. The company earns $-6,020,000.00 in net income (profit) each year or ($2.26) on an earnings per share basis. COLLPLANT HOLDI/S employs 29 workers across the globe.

What is COLLPLANT HOLDI/S's official website?

The official website for COLLPLANT HOLDI/S is http://www.collplant.com.

How can I contact COLLPLANT HOLDI/S?

COLLPLANT HOLDI/S's mailing address is 3 SAPIR ST. WEIZMANN SCIENCE PARK P.O.B. 4132, NESS-ZIONA L3, 74140. The company can be reached via phone at 972-73-232-5600 or via email at [email protected]


MarketBeat Community Rating for COLLPLANT HOLDI/S (NASDAQ CLGN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  35 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  81
MarketBeat's community ratings are surveys of what our community members think about COLLPLANT HOLDI/S and other stocks. Vote "Outperform" if you believe CLGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel